Search results
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 2 days agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
Menthol-flavored e-cigarettes get greenlight by FDA
FOX 2 News Detroit· 1 day agoThe FDA has approved marketing for menthol flavored e-cigarettes, to help people quit smoking. FOX 2 (WJBK) - On Friday the FDA
Top FDA official overrules staff to approve gene therapy that failed trial
Ars Technica· 1 day agoThe Food and Drug Administration (FDA) on Thursday announced expanded approval for a gene therapy to...
FDA approves 1st menthol e-cigarettes, saying they could help adult smokers
WJZY via Yahoo News· 2 days agoThe Food and Drug Administration on Friday authorized the first menthol-flavored electronic...
FDA approves new drug to treat autoimmune liver disease: ‘Giant step forward’
Fox News· 2 days agoA new drug to control liver disease has gotten the green light. The U.S. Food and Drug...
US FDA approves Bristol Myers' colorectal cancer therapy
Colorado Springs Gazette· 2 days agoAbout 34% of the patients who were given the combination treatment showed a partial or complete...
FDA approves new drug to treat autoimmune liver disease: ‘Giant step forward’
Fox News via Yahoo News· 2 days agoThe U.S. Food and Drug Administration has approved the French drugmaker Ipsen’s medication Iqirvo...
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
Zacks via Yahoo Finance· 2 days agoFollowing the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation...
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
InvestorPlace· 2 days agoSarepta Therapeutics (NASDAQ:SRPT) stock jumped about 30% overnight after the Food and Drug...
US FDA clears Kyverna’s KYV-101 cell therapy for Phase II SPS trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has approved Kyverna Therapeutics’ Investigational New...